Fragment (176-191) What is Peptide? What is its use?

In recent years, the increase in the number of obesity and overweight people around the world has pushed health authorities and scientists to search for new and effective obesity treatments. Within these efforts, Fragment (176-191) peptide, a peptide based on a specific portion of growth hormone, is attracting attention for its potential benefits on weight management and fat burning. This article will provide a comprehensive review of what Fragment (176-191) peptide is, how it works, its benefits, effects, safety and future potential.

Fragment (176-191) is a peptide with the amino acid sequence 176-191 of the insulin-like growth factor-1 (IGF-1) hormone. This piece, located in the C-terminus region of the growth hormone, contains the effective region of the growth hormone on fat burning.

Dr. It was derived from growth hormone by Andrew V. Schally and was first considered as a potential agent in the treatment of obesity. However, subsequent research has revealed it to be an ingredient of interest in obesity and weight management due to its lipolytic effects.

Fragment (176-191) can increase lipolysis (fat burning) by partially affecting fat cells. This part of the growth hormone helps break down fats into free fatty acids and glycerol by increasing triglyceride hydrolysis in fat cells.

This process makes it easier to use fat stored in the body as energy. Some animal studies show that Fragment (176-191) may increase fat burning processes.